Evaluating Clinical Pathways for Ovarian Cancer Treatment and Maintenance Therapy

Evaluating Clinical Pathways for Ovarian Cancer Treatment and Maintenance Therapy

User Photo
HMP CME

1 year
416 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Earn CME credit for this activity: https://www.naccme.com/program/2018-802-03 This on-demand activity examines the implications of BRCA mutational status, BRCAness, synthetic lethality, and within-class differences in the mechanisms of action, efficacy and safety, and indications of available and emerging PARP inhibitors for optimal ovarian cancer pathway integration. © 2018 NACCME, an HMP Company
Up Next Autoplay